NZ532414A - Method for preparing heparin form mast cell cultures - Google Patents

Method for preparing heparin form mast cell cultures

Info

Publication number
NZ532414A
NZ532414A NZ532414A NZ53241402A NZ532414A NZ 532414 A NZ532414 A NZ 532414A NZ 532414 A NZ532414 A NZ 532414A NZ 53241402 A NZ53241402 A NZ 53241402A NZ 532414 A NZ532414 A NZ 532414A
Authority
NZ
New Zealand
Prior art keywords
heparin
cells
mast
mast cells
culture
Prior art date
Application number
NZ532414A
Other languages
English (en)
Inventor
Pierre Cans
Jean-Marc Guillaume
Helene Monique Marie Rigal
Original Assignee
Aventis Pharma S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S filed Critical Aventis Pharma S
Publication of NZ532414A publication Critical patent/NZ532414A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NZ532414A 2001-10-22 2002-10-22 Method for preparing heparin form mast cell cultures NZ532414A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0113606A FR2831186B1 (fr) 2001-10-22 2001-10-22 Production d'heparine a partir de cultures de mastocytes
PCT/FR2002/003617 WO2003035886A2 (fr) 2001-10-22 2002-10-22 Preparation d'heparine a partir de cultures de mastocytes

Publications (1)

Publication Number Publication Date
NZ532414A true NZ532414A (en) 2006-12-22

Family

ID=8868558

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ532414A NZ532414A (en) 2001-10-22 2002-10-22 Method for preparing heparin form mast cell cultures

Country Status (18)

Country Link
US (1) US20050042733A1 (fr)
EP (1) EP1438415A2 (fr)
JP (1) JP2005506092A (fr)
KR (1) KR20040071127A (fr)
CN (1) CN1575341A (fr)
AR (1) AR036915A1 (fr)
BR (1) BR0213478A (fr)
CA (1) CA2462714A1 (fr)
CO (1) CO5570711A2 (fr)
FR (1) FR2831186B1 (fr)
HU (1) HUP0401794A2 (fr)
IL (1) IL161066A0 (fr)
MX (1) MXPA04003740A (fr)
NO (1) NO20041633L (fr)
NZ (1) NZ532414A (fr)
PL (1) PL368599A1 (fr)
WO (1) WO2003035886A2 (fr)
ZA (1) ZA200402304B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2853663B1 (fr) * 2003-04-14 2007-08-31 Aventis Pharma Sa Procede d'obtention de lignees de mastocytes a partir de tissus de porcs et procede de production de molecules de type heparine
FR2876386B1 (fr) * 2004-10-12 2007-04-06 Aventis Pharma Sa Lignees de mastocytes porcins produisant des molecules de type heparine
KR100688553B1 (ko) * 2005-06-22 2007-03-02 삼성전자주식회사 코어 사이즈를 감소시킨 반도체 메모리 장치
KR101447123B1 (ko) * 2014-02-27 2014-10-06 박상협 헤파린의 추출 방법
KR102104367B1 (ko) 2019-09-02 2020-04-24 팜앤바이오 주식회사 헤파린나트륨의 제조장치 및 제조방법
CN111979193A (zh) * 2019-09-27 2020-11-24 云南洛宇生物科技有限公司 大鼠骨髓源肥大细胞培养方法
CN110592165B (zh) * 2019-10-18 2021-04-27 福州大学 燕窝中硫酸乙酰肝素/肝素的提取方法与结构解析

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016331A (en) * 1960-01-28 1962-01-09 Ormonoterapia Richter Spa Purification of heparin
AU5810690A (en) * 1989-05-19 1990-12-18 University Of Alabama, The Heparin-producing murine mastocytoma cell lines
JP3507852B2 (ja) * 1993-12-10 2004-03-15 ジェネンテク，インコーポレイテッド アレルギー診断法および抗アレルギー性治療剤のスクリーニング法
FI974321A0 (fi) * 1997-11-25 1997-11-25 Jenny Ja Antti Wihurin Rahasto Multipel heparinglykosaminoglykan och en proteoglykan innehaollande dessa
US6596705B1 (en) * 1998-02-09 2003-07-22 The Regents Of The University Of California Inhibition of L-selectin and P-selection mediated binding using heparin

Also Published As

Publication number Publication date
KR20040071127A (ko) 2004-08-11
ZA200402304B (en) 2004-10-07
CA2462714A1 (fr) 2003-05-01
FR2831186A1 (fr) 2003-04-25
NO20041633L (no) 2004-04-21
PL368599A1 (en) 2005-04-04
BR0213478A (pt) 2004-11-03
MXPA04003740A (es) 2005-06-20
IL161066A0 (en) 2004-08-31
FR2831186B1 (fr) 2004-06-18
CO5570711A2 (es) 2005-10-31
WO2003035886A3 (fr) 2004-02-26
EP1438415A2 (fr) 2004-07-21
US20050042733A1 (en) 2005-02-24
HUP0401794A2 (hu) 2004-11-29
JP2005506092A (ja) 2005-03-03
AR036915A1 (es) 2004-10-13
CN1575341A (zh) 2005-02-02
WO2003035886A2 (fr) 2003-05-01

Similar Documents

Publication Publication Date Title
Shi et al. Chondroitin sulfate: Extraction, purification, microbial and chemical synthesis
US5314876A (en) High molecular mass N,O-sulphated heparosans, process for their preparation and the pharmaceutical compositions which contain them
FR2669932A1 (fr) Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
JPH07501684A (ja) 抗凝固剤およびその調製方法
RU2564566C2 (ru) Ферментация и очистка гепаросана к5
JP2009050271A (ja) 硫酸化グルクロノフカン
CN110331178A (zh) 一种酶切法制备小分子透明质酸的方法及所得小分子透明质酸与其应用
CN101168570B (zh) 海带硫酸多糖的降解方法
US20050042733A1 (en) Method for preparing heparin from mast cell cultures
Jacobsson et al. Biosynthesis of heparin. Effects of n-butyrate on cultured mast cells.
JP3523597B2 (ja) 硫酸化フコガラクタン
Jacobsson et al. Degradation of heparin proteoglycan in cultured mouse mastocytoma cells
JP4262601B2 (ja) 硫酸化フカン
Manzoni et al. Production of K5 polysaccharides of different molecular weight by Escherichia coli
DK2376621T3 (en) BACTERY STOCK AND BACTERY MIXING WITH A FUCANOLYTIC ACTIVITY
JP3683912B2 (ja) 細胞組成物
JP3854063B2 (ja) 糖化合物
US5861505A (en) Synthetic analog of sialic Lewis antigen from bacterial capsular polysaccharide
JP4119890B2 (ja) ナマコ由来硫酸化フカン分解酵素
KR20110135694A (ko) 히알루론산의 탈아세틸화 가수분해효소, 및 이에 의해 탈아세틸화된 히알루론산 및 이의 유도체
JP2008515417A (ja) ヘパリン型分子を産生するブタ肥満細胞株
KR0170064B1 (ko) 아카란 황산을 포함하는 달팽이 엑기스
JP3497817B2 (ja) 硫酸化フコガラクタン分解酵素
JPH0759563A (ja) フコイダン分解酵素及びその製造方法
KR20050016565A (ko) 해삼으로부터 유래된 황산화 푸칸 분해 효소

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed